MANUAL on ALERT ORGANISM SURVEILLANCE

Slides:



Advertisements
Similar presentations
TREATMENT FOR SUPERIMPOSED PSEUDOMONAS AERUGINOSA INFECTION.
Advertisements

East Texas Medical Center – Tyler Annual Physician Education MDRO -Multidrug-Resistant Organisms- Revised: April 2013.
MANUAL CATHETER ASSOCIATED BLOOD STREAM INFECTION (CABSI) SURVEILLANCE
ACT 52 - Healthcare-Associated Infections
HICC An Infection Control Committee provides a forum for multidisciplinary input and cooperation, and information sharing This committee should include.
Introduction to the National Healthcare Safety Network (NHSN) Richard Rodriguez, MPH Connecticut Department of Public Health 4/9/2014 Thank you to CDC.
C. difficile Lab ID Reporting in NHSN Stanley Ostrawski RN, MS, MT(ASCP), CIC Infection Preventionist Consultant.
Antibiogram in Washoe County Nevada – Know the Local Data, Prevent Antimicrobial Resistance Lei Chen, Ph.D., Senior Epidemiologist, Washoe County.
Enoch Omonge University of Nairobi
Hospital Surveillance. Impact of infectious diseases  IDs are considered to be the leading cause of death  Mass population movement  Emerging and re-emerging.
Antimicrobial Resistant Enterobacteriaceae
APIC Chapter 13 Journal Club April 15, 2015
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
NOSOCOMIAL INFECTION SURVEILLANCE METHODS Masud Yunesian, M.D., Epidemiologist.
Objectives After this session, the attendee should be able to:
Preventing Multidrug-Resistant Organisms (MDROs) What the Direct Caregiver Should Know Prepared by: Ann Bailey, RNC, BSN, CIC Joanne Dixon, RN, MN, CIC.
Standard and Expanded Precautions
CHOICE OF ANTIBIOTICS IN THE VIEW OF DEVELOPING ANTIBIOTIC RESISTANCE Dr. Jolanta Miciulevičienė Vilnius City Clinical Hospital National Public Health.
Robynn Cheng Leidig, MPH
CSI 101 Skills Lab 2 Standard Precautions Personal Protective Equipment (PPE) Daryl P. Lofaso, M.Ed, RRT.
Nosocomial infection Hospital Infection. Hospital acquired infections Nosocomial infections are those that originate or occur in a hospital or hospital-like.
Point Prevalence Survey of Hospital- Acquired Infections & Antimicrobial Use in Ireland PPS Data Collector Training April 2012 Background & Introduction.
Antimicrobial resistance surveillance in Ireland Results of invasive Escherichia coli infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.
SPM 100 Clinical Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT.
Using and Sharing Findings from Surveillance: Rates, Ratios Proportions, Data Display & OUTBREAKS Russ Olmsted, MPH, CIC
© Aurora Health Care, Inc. Carbapenem Resistant Enterobacteriaceae The Alphabet Soup of Infection Prevention Aurora Health Care System Infection Prevention.
Zunilda Djanun*, Rudyanto S**, Yulia Rosa***, *Dept. Clinical Pharmacology FMUI/CMH, **ICU CMH, *** Dept. Clinical Microbiology FMUI.
Nebraska Public Health Laboratory 2008 CLSI M100-S18 update Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training.
Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.
Time To Regain Control Management of Multi-Drug Resistant Organisms in Healthcare Settings
Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.
SPM 100 Skills Lab 1 Standard Precautions Sterile Technique Daryl P. Lofaso, M.Ed, RRT Clinical Skills Lab Coordinator.
© 2009 CSTS: The Cardiovascular Surgical Translational Study Using the Centers for Disease Control and Prevention’s National Healthcare Safety Network.
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Carbapenemase- Producing Carbapenem-Resistant Enterobacteriaceae Nicole Hearon, HAI Epidemiologist Surveillance and Investigation Division Indiana State.
Outlines At the completion of this lecture the student will be able to identify the concept and related terms of: Infection- Infection control-
Supplemental testing methods
EARS-Net data on Antimicrobial Resistance in Ireland, Q3 2015
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
INTRODUCTION TO INFECTION CONTROL ICNO Infection Control Unit, Teaching Hospital, Jaffna.
Antimicrobial resistance surveillance in Ireland Results of invasive Klebsiella pneumoniae infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
Országos Epidemiológiai Központ National Center for Epidemiology, Budapest, Hungary Activities in Hungary for preventing AMR and controlling HCAI Emese.
* required for saving Tracking #: Facility ID:*Survey Year: Facility Characteristics *Ownership (check one): □ For profit □ Not for profit, including church.
Multi-Resistant Gram Negative Microorganisms St Elisabeth Hospital Curacao.
1 A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital DIABETES Care; Aug 2006; 29,8 : FM R1 임혜원.
Using Nursing Home Antibiograms To Improve Antibiotic Prescribing and Delivery Training Slides for Nursing Home Nurses Comprehensive Antibiogram Toolkit.
MRSA, ESBLs and Carbapenem Resistance
Tapasyapreeti Mukhopadhyay, Vrushali Patwardhan, Sarman Singh
Etiology of bacteremia in children under 5 years in Southern Mali
Point Prevalence Survey in a Long Term Care Facility, 2016
Outbreak Investigations
Average susceptibility
Nosocomial Infections
Clinico-Pathological Conference (CPC) Meet
Antibiotics sensitivity of microorganism causing nosocomial infections
HAI August 30, 2017.
HAI January 24, 2018.
Changes to 10A NCAC 41A May 5, 2018.
Chapter 1: Introduction to Multidrug – Resistant Organisms
HAI Sept. 25, 2017.
Hospital Antibiotic Stewardship Programs
Neonatal sepsis in Kilifi
WHONET علیرضا ترکی دانشجوي PhD ميکروب شناسی بالینی
بنام خداوند جان و خرد بنام خداوند جان و خرد.
19/ژانويه/17
The need for new antibiotics
TRAINING PRESENTATION
EARS-Net data on Antimicrobial Resistance in Ireland, Q
Presentation transcript:

MANUAL on ALERT ORGANISM SURVEILLANCE Infection Control Unit Quality in Medical Care Section Medical Development Division Ministry of Health Malaysia

Surveillance Surveillance is defined as the systematic active collecting, consolidating, and analyzing data concerning the distribution and determinants of a given disease or event, followed by dissemination of that information to those who can change the results.

Introduction to Alert Organism Surveillance Manual Surveillance is an essential component of the prevention and control of infection in hospitals. It helps to identify risks of infection and reinforces the need for good practices. Preventing outbreak depends on prompt recognition of an infection and instituting control measure to reduce the spread of infection.

Introduction to Alert Organism Surveillance Manual Collection of accurate data allows comparison with other units or institutions and measurement of response to changes in practice. It consists of routine collection of data on infection among patients or staff, analysis and the dissemination of the result so that appropriate action can be implemented.

Cont - Introduction Alert organism surveillance is the continuous active monitoring of the incidence of specified organisms of clinical interests. It is laboratory based surveillance. All laboratories shall use a standard definition for identification and reporting of these alert organisms (See Appendix 1). This surveillance program measures both healthcare associated infection and colonization attributed to the alert organism of interest.

Infection A positive culture from a sterile site (blood, CSF, pleural fluid, peritoneal fluid) unless determined to be contaminant OR A positive culture for the selected organisms isolated from a non-sterile site isolate AND presence of clinical signs and symptoms OR determined by attending physician 

Colonization Contamination Colonization means the presence of microorganisms on skin, mucous membranes, open wounds, or excretions or secretions but is not causing adverse clinical signs or symptoms. Contamination Presence of microorganisms that do not multiply or cause clinical problems  

Objectives The objective of alert organism surveillance program is to determine the rate and trend of specified alert organisms in all hospitals in Malaysia using standardized laboratory and clinical criteria. This is essential for prevention and early detection of outbreak and timely investigation and institution of control measures.

Methodology Population under surveillance The population under surveillance is all inpatients. Exclusion criteria; Cases from Emergency department, clinic, or other outpatient services Cases previously identified at other acute care facilities/hospitals Cases re-admitted with same alert organisms within one year Screening culture

Cont - Methodology The alert organisms under surveillance are: Methicillin-resistant S. aureus (MRSA) Extended Spectrum Beta Lactamases (ESBL) producing Klebsiella pneumoniae Extended Spectrum Beta Lactamases (ESBL) producing Escherichia coli Multidrug resistant Acinetobacter baumanii Carbapenem resistant Enterobacteriaceae (CRE)

Methodology - Case definitions Alert organism case definition must fulfill all three criteria; Isolation of an alert organism from any body sites The patient must be admitted to the ward The case must be “Newly Identified”

Methodology - Case definitions “Newly identified” include: Alert organism identified for the first time during current hospital admission Cases that have been identified at your site but are new case. This means that the patient was exposed and acquired another new infection

Cont - Methodology NOTE: If more than one type of alert organisms were isolated from the same patient, they should be counted separately If a colonized case subsequently develop an infection, the case is counted as a new infection

ALERT ORGANISMS Alert organisms are identified in microbiology laboratory and include organisms such as MRSA and other antibiotic resistant organisms

ALERT ORGANISMS - MRSA MRSA - Staphylococcus aureus that tests oxacillin- or cefoxitin-resistant by standard susceptibility testing methods; or by a positive result for penicillin binding protein 2a (PBP2a) latex agglutination test or molecular testing for mecA gene. May also include positive results of specimens tested by other validated polymerase chain reaction (PCR) tests for MRSA.

ALERT ORGANISMS - ESBL ESBL - are enzymes that mediate resistance to extended-spectrum (third generation) cephalosporins (e.g., ceftazidime, cefotaxime, and ceftriaxone) and monobactams (e.g., aztreonam). CLSI recommends confirmation of potential ESBL-producing isolates of K. pneumoniae or and E. coli  by performing phenotypic testing using both cefotaxime and ceftazidime, alone and in combination with clavulanic acid.

ALERT ORGANISMS MDR - Acinetobacter spp. Acinetobacter baumanii (resistant or intermediate) to three or more antimicrobial classes. β-lactams Aminoglycosides Carbape nems Fluoroquino lones Ampicillin/sulbactam Piperacillin/tazobactam Cefepime Ceftazidime Amikacin Gentamicin Tobramycin Imipenem Meropenem Doripenem Ciprofloxacin Levofloxacin

ALERT ORGANISMS Carbapenem resistant Enterobacteriaceae Enterobacteriaceae that meet the following criteria; Intermediate or resistant to imipenem, meropenem, ertapenem or doripenem using MIC method and confirmed by molecular method

Data Collection Infection Control Personnel (ICP) shall collects data on alert organism on a daily basis from the laboratory. The ICP will liaise with staff in the relevant clinical area to ensure that the infection control practices are implemented. Where appropriate, the Clinical Microbiologist or Scientific Officer will inform the relevant Clinician of the result.

Cont - Data Collection Upon isolation of Alert Organisms, the ICP should investigate and complete the Alert Organism Surveillance Form (Appendix 2) and Line-listing Form (Appendix 3). The specific type of infection is determined based on the CDC/NHSN Surveillance Definition of Healthcare-Associated Infection and Criteria for Specific Types of Infections in the Acute Care Setting. The classification of infection in relation to the health care facility is detailed in Appendix 4.

Appendix 2 ALERT ORGANISM SURVEILLANCE FORM MINISTRY OF HEALTH MALAYSIA MDRO/KKM/2012/1 Appendix 2 HOSPITAL: DATE: A. DEMOGRAPHIC DETAILS: 1. Name: 2. MRN: 3. IC/ Passport No: 4. Date of Admission: 5. Ward on Admission: 6. Diagnosis on Admission: 7. Previous Encounter to Health Facility/ long Term Nursing Care: No Yes If yes to (7), specify: Name of Health Facility/ Long Term Nursing Care: Date of Discharge:

B. POSITIVE CULTURE: Diagnosis on Specimen Taken: 2. Date of Positive Report: 3. Date of Specimen Taken: 4. Specimen Type: 5. Location (Ward) During Specimen Collection:

C. ORGANISM ISOLATED:   MRSA 2. ESBL K penumoniae 3. ESBL Escherichia coli 4. MDR Acinetobacter baumannii 5. Carbapenem resistant Enterobacteriaceae (CRE) D. ISOLATE STATUS: Infection Colonization [ Proceed to F ] Contaminant [Omit subsequent questions]

E. TYPE OF INFECTION: Blood stream infection (Primary infection) 2. Surgical site infection 3. Urinary tract infection 4. Ventilator acquired pneumonia 5. Hospital acquired pneumonia (non-VAP) 6. Clinical Sepsis 7. OTHERS , specify ________________

1. Third Generation Cephalosporin F. CULTURE POSITIVE STATUS   Health Care-Associated, Own Facility 2. Health Care-Associated, other MOH Facility 3. Health Care-Associated, non MOH Facility 4. Not Health Care Associated G. ANTIBIOTIC (s) EXPOSURE WITHIN LAST 3 MONTHS 1. Third Generation Cephalosporin 2. Carbapenem 3. Quinolone

Diagnosis On Admission Diagnosis On Specimen Taken Appendix 3 LINE LISTING FORM No PATIENT DETAILS POSITIVE CULTURE   Name Ic/ Passport Date Of Admission Ward On Admission Diagnosis On Admission Previous Encounter Date Of Discharge Diagnosis On Specimen Taken Date Of Report Date Of Specimen Type Of Specimen Ward Organism Isolated Isolate Status Type Of Infection HCAI Status

Classification Of Infection In Relation To The Healthcare Facility Appendix 4 1. Healthcare Associated, Own Hospital An alert organism case identified 48 hours after the patient was admitted to your hospital OR An alert organism case identified within one month for surgical procedure without implant or one year with implant An alert organism case identified less than 48 hours after admission to your hospital AND the patient has history of encounter with any procedures at your acute care / outpatient care facility

2. Healthcare Associated, Another Health Care Facility [Other MOH facility or Non MOH facility] An alert organism case identified 48 hours or less after admission to your hospital AND The case had an encounter with another healthcare facility, either as an inpatient or as an outpatient (including emergency care, ambulatory care, and outpatient clinics), within the last 12 months for MRSA and 3 months for gram negative bacteria.

Not Healthcare Associated 3. Not Healthcare Associated An alert organism case identified less than 48 hours after admission to your acute care facility AND There was no exposure to any health care facility, either as an inpatient or an outpatient

Not Healthcare Associated 3. Not Healthcare Associated (CA MRSA) Community-associated MRSA cases are defined as meeting all the criteria below: No previous history of MRSA MRSA identified ≤48 hours after hospital admission No hospitalization in the previous 12 months No surgery or dialysis in the previous 12 months No residence in a long-term care facility in the previous 12 months No indwelling catheter or medical device (e.g. foley catheter, IV line, tracheostomy, feeding tube)

Data Analysis And Reporting The inpatient data will be used as denominators to calculate the incidence rate of alert organisms in each hospital. Following data will be collected: Total number of hospital admissions Total number of patient days (to collect 12 midnight statistics from Record Office)

Data Analysis And Reporting Cont- Data Analysis And Reporting All hospitals shall send the aggregated data on monthly basis to the State Coordinator using Appendix 5. The state Infection Control Coordinator shall then send the compiled data to the Infection Control Unit, Quality in Medical Care Section, MOH.

Data Analysis And Reporting Data Analysis And Reporting Cont - Data Analysis And Reporting The data will be analyzed and result will be disseminated every 6-monthly. A yearly report will be published which will include; Incidence of each healthcare-associated alert organisms per 100 admissions Incidence of each healthcare-associated alert organisms per 1,000 patient-days

Cont - Data Analysis And Reporting RATES: Total no. of HCAI cases x 100 Total admission of the month 2. Total no. of HCAI cases x 1000 Total patient days for the month

Patient Days Patient days are the total number of days that patients are in the location during the selected time period. Example: ten patients were in the unit on the 1st day of the month; 12 on day 2; 11 on day 3; 13 on day 4; 10 on day 5; 6 on day 6; and 10 on day 7; and so on. If we counted the patients in the unit from day 1 through 7, we would add 10+12+11+13+10+6+10 for a total of 72 patient days for the 1st week of the month. If we continued for the entire month, the number of patient days for the month is simply the sum of the daily counts.

MONTHLY ALERT ORGANISM REPORTING FORM MINISTRY OF HEALTH MALAYSIA Appendix 5 MDRO/KKM/2012/2 STATE:   HOSPITAL: MONTH/ YEAR: TOTAL ADMISSION: TOTAL PATIENT DAYS: days ORGANISM NO OF INFECTION RATE OF INFECTION NO OF COLONISER TOTAL RATE (INFECTION+COLONISER) per 100 admission per 1000 patient days MRSA - HA ESBL: Klebsiella pneumoniae ESBL: Escherichia coli MRO Acinetobacter baumannii Carbapenem resistant Enterobacteriaceae (CRE) ** only report data from own facility

REPORTED BY: Name: Designation: Date: VERIFIED BY: Name: Designation: Date:

PROCESS FLOW CHART FOR MANAGEMENT OF ALERT ORGANISM SURVEILLANCE Isolate of Alert Organism Clinical Microbiologist/ Scientific Officer informs the result to Clinician where appropriate ICP collects data on daily basis from the laboratory Complete the Alert Organism Surveillance Form (Appendix 2) and the Line Listing (Appendix 3) Classify the infection according to types and its relation to healthcare facility Analyse the data at the end of the month and complete Monthly Alert Organism Reporting Form (Appendix 5) to get the rate of infection for each type of alert organism

Prepare report using Ms EXCEL/ (SPCC) and submit to HIACC Chairman Submit Monthly Alert Organism Reporting Form (Appendix 5) to the State Coordinator for compilation by 10th of every month State Coordinator to submit the compiled report to Infection Control Unit, Medical Development Division, MOH by 20th of every month Data management by the National Secretariat

THANK YOU